MarketInOut Stock Screener Log In | Sign Up

AEON Biopharma Inc

NYSE • Healthcare • Biotechnology • Quote as of 11/18/2026 16:00
AEON Biopharma Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNYSE
Market Capitalization10.09 mln
Float28.17 mln
Earnings Date11/16/2026

Piotroski F-Score

2 / 9
Weak

1-Year Forecast

1.82
Transformational upside

Relative Strength

4 / 100
Severely lagging

Debt / Equity

1.17
Elevated leverage

ROE

225
Extraordinary

ROA

-674
Deeply negative

Business Description

AEON Biopharma is a California-based medical company working to bring new treatments to patients suffering from serious and often overlooked conditions. Its main focus is a drug called prabotulinumtoxinA, a form of botulinum toxin being studied for conditions such as cervical dystonia, chronic migraine, gastroparesis, and post-traumatic stress disorder. The company operates through partnerships with Daewoong Pharmaceutical and Viatris to advance its clinical programs.

Key Fundamentals

EPS-4.39
ROE225
ROIC-474
ROA-674
EBITDA, mln-54.54
EV / EBITDA-0.11
EV / EBIT-0.11

Quote Details

Last 0.1243
Change 0.0109 (9.61%)
Open 0.1154
Volume 1,835,839
Turnover 228,195
Average Volume 1,266,773

Financial Ratios

Leverage Ratio5.92
Current Ratio0.54
Price / Book3.00
Debt / Equity1.17

Financial Strength

Piotroski F-Score 2 / 9
1-Year Target Price1.82
Short Ratio0.42
Short % of Float5.81

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -27.48% 6 / 100   
1 Month -46.31% 6 / 100   
2 Months -54.07% 12 / 100   
6 Months -85.6% 4 / 100   
1 Year -85.71% 7 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog